Hong Kong stock market abnormal movement | Ke Li Pharmaceutical-B (01672.HK) rebounds nearly 3% IL-17 inhibitor ASC50 American Phase I study achieves positive top-line results.

According to the Wisdom Finance and Economics APP, GL Biochem (01672.HK) has rebounded nearly 3% recently. As of press time, it has risen by 2.01% to HK$13.2, with a transaction volume of HK$31.8424 million.